Daniel serves as the Director of Research for aMoon Alpha. Alpha Research is about building an analytical research platform to manage the growing body of knowledge and expertise at aMoon Fund. Daniel also assists aMoon's portfolio companies with data-driven insights and competitive intelligence.
Daniel joined in the summer 2017 as one of the early members of the aMoon team. He was attracted to the team's vision of a value-based organization that focuses on "doing well by doing good".
Prior to aMoon, Daniel worked as an investment banker in New York, advising on mergers and acquisitions, equity and debt capital, and royalty monetization in the healthcare industry. At MTS Health Partners, Daniel served on deal teams advising a total deal volume of ~$2 billion. He was also Senior Analyst at Lazard, where he advised corporate clients on activist campaigns.
Daniel earned his BA in Financial Economics from Columbia University, where he focused on Biopharmaceutical Development & Regulation.